5 Most Promising Small-Cap Stocks According to Analysts

Page 5 of 5

1. Dynavax Technologies Corporation (NASDAQ:DVAX)

Number of Hedge Fund Holders: 22

Average Upside Potential as of February 10: 126.24%

Dynavax Technologies Corporation (NASDAQ:DVAX) is an American commercial-stage biotechnology company involved in the development and commercialization of novel vaccines in the United States. On January 31, Dynavax Technologies Corporation (NASDAQ:DVAX) announced that the company has been approved for uplisting to the Nasdaq Global Select Market.

On January 9, Dynavax Technologies Corporation (NASDAQ:DVAX) announced that the company’s preliminary HEPLISAV-B revenue for fiscal 2022 amounted to $126 million, up 104% year over year. Moreover, the company also announced that as of December 31, 2022, Dynavax Technologies Corporation (NASDAQ:DVAX) holds roughly $624 million in cash and cash equivalents, and marketable securities.

Dynavax Technologies Corporation (NASDAQ:DVAX) is one of analysts’ most promising small-cap stocks to buy now. The stock has a consensus Buy rating among analysts and an average price target of $25, which represents an upside of 126.24% from current levels.

At the end of Q3 2022, 22 hedge funds were long Dynavax Technologies Corporation (NASDAQ:DVAX) and disclosed positions worth $189.3 million in the company. As of December 31, Fisher Asset Management is the top stockholder in the company and owns over 4 million shares.

Follow Dynavax Technologies Corp (NASDAQ:DVAX)

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a look at 15 Fastest Growing Countries in Asia and 12 Most Undervalued Retail Stocks.

Page 5 of 5